Clinical trial
Electroconvulsive Therapy for Treatment of Alzheimer´s Disease
NCT02438202 is registered in ClinicalTrials.gov with Central Institute of Mental Health, Mannheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electroconvulsive Therapy for Treatment of Alzheimer´s Disease
- Lead sponsor
- Central Institute of Mental Health, Mannheim
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- January 31, 2028
- Enrollment
- 15 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease